Annual Accounts Payable
$926.00 K
+$192.00 K+26.16%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual accounts payable is $926.00 thousand, with the most recent change of +$192.00 thousand (+26.16%) on December 31, 2023.
- During the last 3 years, DMAC annual accounts payable has fallen by -$173.00 thousand (-15.74%).
- DMAC annual accounts payable is now -22.30% below its all-time high of $1.19 million, reached on December 31, 2012.
Performance
DMAC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.17 M
+$412.00 K+54.28%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly accounts payable is $1.17 million, with the most recent change of +$412.00 thousand (+54.28%) on September 30, 2024.
- Over the past year, DMAC quarterly accounts payable has increased by +$308.00 thousand (+35.69%).
- DMAC quarterly accounts payable is now -34.21% below its all-time high of $1.78 million, reached on March 31, 2023.
Performance
DMAC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DMAC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.2% | +35.7% |
| 3 y3 years | -15.7% | +67.5% |
| 5 y5 years | +91.7% | +67.5% |
DMAC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.9% | -34.2% | +170.4% |
| 5 y | 5-year | -15.7% | +408.8% | -34.2% | +543.4% |
| alltime | all time | -22.3% | +1637.3% | -34.2% | +2097.0% |
DiaMedica Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.17 M(+54.3%) |
| Jun 2024 | - | $759.00 K(+6.0%) |
| Mar 2024 | - | $716.00 K(-22.7%) |
| Dec 2023 | $926.00 K(+26.2%) | $926.00 K(+7.3%) |
| Sep 2023 | - | $863.00 K(+0.8%) |
| Jun 2023 | - | $856.00 K(-51.9%) |
| Mar 2023 | - | $1.78 M(+142.5%) |
| Dec 2022 | $734.00 K(+44.2%) | $734.00 K(-15.0%) |
| Sep 2022 | - | $864.00 K(+38.5%) |
| Jun 2022 | - | $624.00 K(+44.1%) |
| Mar 2022 | - | $433.00 K(-14.9%) |
| Dec 2021 | $509.00 K(-53.7%) | $509.00 K(-27.2%) |
| Sep 2021 | - | $699.00 K(+192.5%) |
| Jun 2021 | - | $239.00 K(-65.3%) |
| Mar 2021 | - | $689.00 K(-37.3%) |
| Dec 2020 | $1.10 M(+503.8%) | $1.10 M(+52.6%) |
| Sep 2020 | - | $720.00 K(+30.4%) |
| Jun 2020 | - | $552.00 K(+24.3%) |
| Mar 2020 | - | $444.00 K(+144.0%) |
| Dec 2019 | $182.00 K(-62.3%) | $182.00 K(-41.7%) |
| Sep 2019 | - | $312.00 K(+19.1%) |
| Jun 2019 | - | $262.00 K(-61.8%) |
| Mar 2019 | - | $685.00 K(+41.8%) |
| Dec 2018 | $483.00 K(-5.8%) | $483.00 K(+20.5%) |
| Sep 2018 | - | $400.90 K(-31.6%) |
| Jun 2018 | - | $586.10 K(-8.0%) |
| Mar 2018 | - | $636.90 K(+24.2%) |
| Dec 2017 | $513.00 K(+105.2%) | $513.00 K(-2.4%) |
| Sep 2017 | - | $525.40 K(-5.1%) |
| Jun 2017 | - | $553.50 K(+2.3%) |
| Mar 2017 | - | $541.10 K(+116.4%) |
| Dec 2016 | $250.00 K | $250.00 K(-76.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $1.05 M(+5.9%) |
| Jun 2016 | - | $991.90 K(+67.6%) |
| Mar 2016 | - | $591.70 K(-12.2%) |
| Dec 2015 | $674.10 K(+81.2%) | $674.10 K(+19.3%) |
| Sep 2015 | - | $565.10 K(+108.8%) |
| Jun 2015 | - | $270.70 K(+9.5%) |
| Mar 2015 | - | $247.20 K(-29.7%) |
| Sep 2014 | - | $351.70 K(-6.4%) |
| Jun 2014 | - | $375.60 K(+94.4%) |
| Mar 2014 | - | $193.20 K(-48.1%) |
| Dec 2013 | $372.10 K(-68.8%) | $372.10 K(+16.9%) |
| Sep 2013 | - | $318.20 K(-13.5%) |
| Jun 2013 | - | $367.70 K(-70.4%) |
| Mar 2013 | - | $1.24 M(+4.2%) |
| Dec 2012 | $1.19 M(+756.7%) | $1.19 M(+165.2%) |
| Sep 2012 | - | $449.30 K(-35.1%) |
| Jun 2012 | - | $692.20 K(+397.6%) |
| Dec 2011 | $139.10 K(-48.9%) | $139.10 K(-47.0%) |
| Sep 2011 | - | $262.50 K(+100.2%) |
| Jun 2011 | - | $131.10 K(-43.5%) |
| Mar 2011 | - | $232.00 K(-6.8%) |
| Sep 2008 | - | $248.80 K(-24.9%) |
| Jun 2008 | - | $331.40 K(+9.5%) |
| Mar 2008 | - | $302.70 K(+11.1%) |
| Dec 2007 | $272.40 K(+411.1%) | $272.40 K(+166.0%) |
| Sep 2007 | - | $102.40 K(-74.0%) |
| Jun 2007 | - | $393.60 K(+155.3%) |
| Mar 2007 | - | $154.20 K(+189.3%) |
| Dec 2006 | $53.30 K(-5.7%) | $53.30 K(-10.0%) |
| Sep 2006 | - | $59.20 K(+4.8%) |
| Dec 2005 | $56.50 K(-91.5%) | $56.50 K |
| Dec 2004 | $665.30 K | - |
FAQ
- What is DiaMedica Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual accounts payable year-on-year change?
- What is DiaMedica Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly accounts payable year-on-year change?
What is DiaMedica Therapeutics annual accounts payable?
The current annual accounts payable of DMAC is $926.00 K
What is the all time high annual accounts payable for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual accounts payable is $1.19 M
What is DiaMedica Therapeutics annual accounts payable year-on-year change?
Over the past year, DMAC annual accounts payable has changed by +$192.00 K (+26.16%)
What is DiaMedica Therapeutics quarterly accounts payable?
The current quarterly accounts payable of DMAC is $1.17 M
What is the all time high quarterly accounts payable for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly accounts payable is $1.78 M
What is DiaMedica Therapeutics quarterly accounts payable year-on-year change?
Over the past year, DMAC quarterly accounts payable has changed by +$308.00 K (+35.69%)